Advance glycation endproducts or glycotoxins: Underevaluated components of diet?;Produits de glycation avancée ou glycotoxines: Des oubliés de la diététique?

Revue du Praticien

Volumn 51, Issue 13, 2001, Pages 1397-1399

  Wautier, J L ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; TOXIN;

DIET; ENZYME LINKED IMMUNOSORBENT ASSAY; SHORT SURVEY;

AGED; ANIMALS; DIABETES MELLITUS; DIABETES MELLITUS, EXPERIMENTAL; DIET; ENZYME-LINKED IMMUNOSORBENT ASSAY; FOOD ANALYSIS; GLYCOSYLATION; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; KIDNEY FAILURE, CHRONIC; MICE; RABBITS; RATS; RESEARCH; RISK FACTORS; TIME FACTORS;

EID: 17444433565     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (7)

1. Produits de glycation avancée ou produits de Maillard
2. Activation of RAGE: A mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis
3. Orally absorbed reactive glycation products (glycotoxins): An environmental risk factor in diabetic nephropathy
4. Nutritional and toxicological aspects of the Maillard browning reactions in foods
5. Advanced glycation end products up regulate gene expression found in diabetic glomerular disease
6. Exogenous advanced glycosylation end products induce complex vascular dysfunctions in normal animals: A model for diabetic and aging complications
7. Coronary artery responses to physiological stimuli are improved by deferoxamine but not arginine in non insulin dependent diabetic patients with angiographically normal arteries and no other risk factors